Caris Life SciencesvsThermo Fisher Scientific

CAI and TMO stock compared: price, dividend, valuation and results, from SEC filings.

CAI

Caris Life Sciences, Inc.

$21.00

Value $5.9B

-8.85%
CAI's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

Caris Life Sciences (CAI) has a market value of $5.9B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, CAI moved -11.9% and TMO +19.9%. The P/E is 61.8 for CAI and 36.3 for TMO. Dividend yield: CAI none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CAI$5.9B

    TMO$257B

    TMO is 43 times CAI

  • Revenue, 12 months

    CAI$1.0B

    TMO$47.4B

    TMO is 45 times CAI

  • Net income, 12 months

    CAI$96M

    TMO$7.1B

    TMO is 74 times CAI

  • Operating margin

    CAI13.4%

    TMO17.9%

    4.5 points apart

  • ROIC

    CAI11.5%

    TMO8.2%

    3.3 points apart

  • P/E

    CAI61.8

    TMO36.3

    CAI is 1.7 times TMO

  • Dividend yield

    CAI0.0%

    TMO0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CAI-12.0%

TMO+19.9%

75100125DecFebAprJunAugOct
Returns by period
PeriodCAIWith dividendsTMOWith dividends
1 year since November 14, 2025-11.9%Price -11.9%+19.9%Price +19.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CAICaris Life SciencesTMOThermo Fisher Scientific

Valuation

CAITMO
Valuation
Price$21.00$691.33
Market value$5.9B$257B
Enterprise value (EV)–$292B
P/E61.836.3
P/E, 5-year median–32.7
P/B9.34.7
EV/EBIT–34.5
Free cash flow yield0.5%3.0%

Results and growth

CAITMO
Results and growth
Revenue, 12 months$1.0B$47.4B
Net income, 12 months$96M$7.1B
Free cash flow, 12 months$29M$7.6B
Earnings per share, 12 months$0.34$18.96
Revenue growth, year on year97.0%3.9%
Revenue growth a year, past+62.9%over 2 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

CAITMO
Margins and returns on capital
Gross margin––
Operating margin13.4%17.9%
Net margin9.2%14.9%
ROIC11.5%8.2%
ROE16.7%13.4%

Balance sheet

CAITMO
Balance sheet
Cash–$6.1B
Total debt–$41.4B
Net debt / EBITDA–3.7
Interest cover3.3×5.5×

Dividends and buybacks

CAITMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield0.0%1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CAI or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Caris Life Sciences or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 43.3 times Caris Life Sciences ($5.9B), at today's prices.

How did CAI and TMO stock do over the last 1 years?

Since November 14, 2025, CAI's price moved -11.9% and TMO's +19.5%. With dividends: CAI -11.9% (-11.9% a year), TMO +19.9% (+19.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, CAI or TMO?

The dividend yield at today's price is none for Caris Life Sciences and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of CAI and TMO?

At today's price, the P/E is 61.8 for CAI and 36.3 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Caris Life Sciences or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 9.2% for Caris Life Sciences and 14.9% for Thermo Fisher Scientific, and the operating margin 13.4% and 17.9%. Revenue was $1.0B and $47.4B.

Which is the better investment, Caris Life Sciences or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.